1. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. (15th November 2012) Authors: Reid, A.L.; Millward, M.; Pearce, R.; Lee, M.; Frank, M.H.; Ireland, A.; Monshizadeh, L.; Rai, T.; Heenan, P.; Medic, S.; Kumarasinghe, P.; Ziman, M. Journal: British journal of dermatology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Melanoma circulating tumor cells: Benefits and challenges required for clinical application. (28th June 2018) Authors: Marsavela, G.; Aya-Bonilla, C.A.; Warkiani, M.E.; Gray, E.S.; Ziman, M. Journal: Cancer letters Issue: Volume 424(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗